Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C27H39ClN2O2 |
| Molecular Weight | 459.064 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)C1=CC(CN2CCN(CC(O)C3=CC=C(Cl)C=C3)CC2)=CC(=C1O)C(C)(C)C
InChI
InChIKey=ZGSFWANJADAZQC-UHFFFAOYSA-N
InChI=1S/C27H39ClN2O2/c1-26(2,3)22-15-19(16-23(25(22)32)27(4,5)6)17-29-11-13-30(14-12-29)18-24(31)20-7-9-21(28)10-8-20/h7-10,15-16,24,31-32H,11-14,17-18H2,1-6H3
| Molecular Formula | C27H39ClN2O2 |
| Molecular Weight | 459.064 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/10583001
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10583001
AM-36 is a novel arylalkylpiperazine with combined antioxidant and Na(+) channel blocking actions. This compound was discovered as a four-year Amrad-funded program with the Departments of Pharmacology and Chemistry at Monash University. In preclinical studies was shown, that AM-36 might have great promise in the acute treatment of human stroke. But these investigation were discontinued.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18237464
Curator's Comment: Known to be CNS penetrant in rats. Human data not available
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Sodium channel Sources: https://www.ncbi.nlm.nih.gov/pubmed/15165842 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18237464
in rats: nominal i.v. doses are: 0.2, 1 and 3 mg/kg
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15165842
AM-36 inhibited batrachotoxinin (BTX)-sensitive Na+ channel binding in rat brain homogenates with an IC50 of 0.28 uM. Veratridine (100 uM)-induced neurotoxicity in murine cerebellar granule cells was completely inhibited by AM-36 (1.7 uM) compared to only partial inhibition by sipatrigine (26 uM). Veratridine-stimulated glutamate release, as measured through a microdialysis probe in the cortex of anesthetised rats, was inhibited by 90% by superfusion of AM-36 (1000 uM).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:11:18 GMT 2025
by
admin
on
Mon Mar 31 22:11:18 GMT 2025
|
| Record UNII |
08OBY024NY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9890390
Created by
admin on Mon Mar 31 22:11:18 GMT 2025 , Edited by admin on Mon Mar 31 22:11:18 GMT 2025
|
PRIMARY | |||
|
08OBY024NY
Created by
admin on Mon Mar 31 22:11:18 GMT 2025 , Edited by admin on Mon Mar 31 22:11:18 GMT 2025
|
PRIMARY | |||
|
199467-52-2
Created by
admin on Mon Mar 31 22:11:18 GMT 2025 , Edited by admin on Mon Mar 31 22:11:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |